GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impact BioMedical Inc (AMEX:IBO) » Definitions » Net Income (Continuing Operations)

Impact BioMedical (Impact BioMedical) Net Income (Continuing Operations) : $-4.56 Mil (TTM As of Mar. 2024)


View and export this data going back to 2050. Start your Free Trial

What is Impact BioMedical Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Impact BioMedical's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was $-1.00 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was $-4.56 Mil.


Impact BioMedical Net Income (Continuing Operations) Historical Data

The historical data trend for Impact BioMedical's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impact BioMedical Net Income (Continuing Operations) Chart

Impact BioMedical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
-0.65 - -7.26 -7.26 -4.41

Impact BioMedical Quarterly Data
Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.85 -1.12 -1.18 -1.26 -1.00

Impact BioMedical Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Impact BioMedical  (AMEX:IBO) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Impact BioMedical Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Impact BioMedical's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Impact BioMedical (Impact BioMedical) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
275 Wiregrass Parkway, West Henrietta, NY, USA, 14586
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.

Impact BioMedical (Impact BioMedical) Headlines

No Headlines